Inovio Pharmaceuticals
INO
#9821
Rank
NZ$0.13 B
Marketcap
NZ$1.68
Share price
-4.89%
Change (1 day)
-33.21%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): NZ-$3.89

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.92. In 2025 the company made an earnings per share (EPS) of NZ-$3.13 an increase over its 2024 EPS that were of NZ-$6.82.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.8924.36%
2025NZ-$3.13-54.18%
2024NZ-$6.82-35.14%
2023NZ-$10.52-56.62%
2022NZ-$24.25-19.54%
2021NZ-$30.1435.9%
2020NZ-$22.18-11.57%
2019NZ-$25.0815.24%
2018NZ-$21.77-2.78%
2017NZ-$22.396.93%
2016NZ-$20.94134.88%
2015NZ-$8.91-29.51%
2014NZ-$12.64-57.34%
2013NZ-$29.64146.55%
2012NZ-$12.0220.83%
2011NZ-$9.95-29.41%
2010NZ-$14.10-48.48%
2009NZ-$27.3610%
2008NZ-$24.8711.11%
2007NZ-$22.39-41.3%
2006NZ-$38.14-66.91%
2005NZ-$115.25110.61%
2004NZ-$54.72-61.63%
2003NZ-$142.61186.67%
2002NZ-$49.75
2001N/A-100%
2000NZ-$39.80-63.64%
1999NZ-$109.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.09-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.13-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.82-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.18-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.71-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$1.40-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA